EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity

Bosa Mirjanić-Azarić, Smiljana Mijić, Zana Radić-Savić, Siniša Stanković, Dragana Malčić-Zanić, Egeljić Nataša Mihailović, Đorđe Stojisavljević, Bojana Ivetić, Nataša Bogavac-Stanojević

Journal of Medical Biochemistry · 2026 · 45 (4) · 889-896

DOI: 10.5937/jomb0-61502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Biochemistry, 2026. Verfasst von Bosa Mirjanić-Azarić und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Banja Luka, Faculty of Medicine, Department of Medical Biochemistry, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry for Scientific/Technological Development, Higher Education and Information Society, Government of the Republic of Srpska.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This pilot study aimed to assess the potential of cystatin C (Cys C) as a biomarker in non-Hodgkin lymphoma (NHL) and to explore its association with paraoxonase 1 (PON1) activity.

Methods

The study included 44 patients with B-cell NHL and 44 healthy subjects. Cys C was measured using the Cobas e 801 analyser (Roche Diagnostics GmbH, Mannheim, Germany), while PON1 and TAS were measured on the ILab 300+ system (Instrumentation Laboratory, Milan, Italy).

Results

The serum level of Cys C (mg/L) was significantly higher in NHL patients compared to control subjects: 1.03 (0.88-1.24) vs 0.83 (0.78-0.90), P<0.001. The diagnostic performance of Cys C, as assessed by the area under the ROC curve (AUC), was 0.812 (95% CI: 0.732-0.902). The optimal cut-off value for Cys C was 0.870 mg/L, with sensitivities and specificities of 77.1% and 75.6%, respectively. A significant negative correlation was observed between Cys C and PON1 activity (r=-0.42, P=0.010) in NHL patients.

Conclusion

This study underscores the potential of Cys C as a biomarker in NHL. Notably, in the multivariable analysis, Cys C was the dominant independent predictor of NHL, with each 1 SD increase in Cys C associated with approximately 11-fold higher odds of NHL. Furthermore, the negative correlation between Cys C and PON1, identified for the first time in patients with NHL, may offer valuable insights into the molecular mechanisms underlying this malignancy.

Schlagwörter

Stichwörter der Autor:innen

cystatin Cnon-Hodgkin lymphomaparaoxonase 1

Autor:innen und Institutionen

  • University of Banja Luka, Faculty of Medicine, Department of Medical Biochemistry, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
  • Aqualab laboratory, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
  • University Clinical Centre of the Republic of Srpska, Department of Nuclear Medicine, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
  • University of Banja Luka, Faculty of Medicine, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
  • University Clinical Centre of the Republic of Srpska, Institute of Laboratory Diagnostics, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
  • University of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade.

Förderung

  • Ministry for Scientific/Technological Development, Higher Education and Information Society, Government of the Republic of Srpska

Zitieren

APA

Mirjanić-Azarić, B., Mijić, S., Radić-Savić, Z., Stanković, S., Malčić-Zanić, D., Mihailović, E. N., Stojisavljević, Đ., Ivetić, B., & Bogavac-Stanojević, N. (2026). Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity. Journal of Medical Biochemistry, 45(4), 889-896. https://doi.org/10.5937/jomb0-61502

Vancouver

Mirjanić-Azarić B, Mijić S, Radić-Savić Z, Stanković S, Malčić-Zanić D, Mihailović EN, et al. Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity. Journal of Medical Biochemistry. 2026;45(4):889-896. doi:10.5937/jomb0-61502

BibTeX
@article{MirjaniAzari2026,
  author = {Mirjanić-Azarić, Bosa and Mijić, Smiljana and Radić-Savić, Zana and Stanković, Siniša and Malčić-Zanić, Dragana and Mihailović, Egeljić Nataša and Stojisavljević, Đorđe and Ivetić, Bojana and Bogavac-Stanojević, Nataša},
  title = {Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity},
  journal = {Journal of Medical Biochemistry},
  year = {2026},
  volume = {45},
  number = {4},
  pages = {889--896},
  doi = {10.5937/jomb0-61502}
}
Kostenlos starten →